Scancell Holdings PLC — RNS

Regulatory news across SCLP

Date	Time	Date	TitleTitle (filtered)	Source
23/07/26	11:11:00	23 Jul 2026	Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing	Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing	GNW
28/04/26	07:00:00	28 Apr 2026	Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study	Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study	GNW
06/07/16	08:00:06	6 Jul 2016	SCIB1 compelling survival data in melanoma	SCIB1 compelling survival data in melanoma	RNS
29/06/16	17:40:39	29 Jun 2016	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
29/06/16	17:35:19	29 Jun 2016	Price Monitoring Extension	Price Monitoring Extension	RNS
17/06/16	08:00:10	17 Jun 2016	SCIB1 Drug Product Supply	SCIB1 Drug Product Supply	RNS
18/05/16	08:00:08	18 May 2016	Opens US Headquarters in San Diego	Opens US Headquarters in San Diego	RNS
11/04/16	17:11:48	11 Apr 2016	Holding(s) in Company	Holding(s) in Company	RNS
06/04/16	08:00:08	6 Apr 2016	Holding(s) in Company	Holding(s) in Company	RNS
04/04/16	11:17:58	4 Apr 2016	Result of the open offer	Result of the open offer	RNS
01/04/16	08:00:08	1 Apr 2016	Result of open offer	Result of open offer	RNS
11/03/16	07:00:09	11 Mar 2016	Strategic collaboration with Karolinska Institutet	Strategic collaboration with Karolinska Institutet	RNS
11/03/16	07:00:09	11 Mar 2016	Posting of Circular	Posting of Circular	RNS
09/03/16	14:07:24	9 Mar 2016	Placing and Open Offer Close	Placing and Open Offer Close	RNS
09/03/16	07:00:09	9 Mar 2016	Proposed Placing and Open Offer	Proposed Placing and Open Offer	RNS
27/01/16	09:00:01	27 Jan 2016	Amendment to Options	Amendment to Options	RNS
27/01/16	07:00:07	27 Jan 2016	Half Yearly Report	Half Yearly Report	RNS
11/01/16	07:00:06	11 Jan 2016	SCIB1 Early Immune Effect Observed by ImmunTraCkeR	SCIB1 Early Immune Effect Observed by ImmunTraCkeR	RNS
07/01/16	07:00:08	7 Jan 2016	Directorate Change	Directorate Change	RNS
05/01/16	07:00:07	5 Jan 2016	Key Moditope paper published in Cancer Research	Key Moditope paper published in Cancer Research	RNS
18/12/15	07:00:06	18 Dec 2015	US Phase II combination study with SCIB1	US Phase II combination study with SCIB1	RNS
20/10/15	14:05:07	20 Oct 2015	Results of AGM	Results of AGM	RNS
20/10/15	08:00:07	20 Oct 2015	AGM Business Update	AGM Business Update	RNS
14/10/15	08:00:33	14 Oct 2015	Directorate Change	Directorate Change	RNS
18/09/15	08:00:06	18 Sept 2015	Final Results for the year ended 30 April 2015	Final Results for the year ended 30 April 2015	RNS
27/08/15	17:42:54	27 Aug 2015	Notice of AGM	Notice of AGM	RNS
30/07/15	08:00:54	30 Jul 2015	Collaboration with ImmunID	Collaboration with ImmunID	RNS
09/07/15	08:00:11	9 Jul 2015	Patient recruitment completed for SCIB1 trial	Patient recruitment completed for SCIB1 trial	RNS
02/06/15	08:00:17	2 Jun 2015	SCIB1 data update in resected melanoma patients	SCIB1 data update in resected melanoma patients	RNS
24/03/15	16:40:46	24 Mar 2015	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
24/03/15	16:35:24	24 Mar 2015	Price Monitoring Extension	Price Monitoring Extension	RNS
24/03/15	07:00:36	24 Mar 2015	SCIB2 synergy with checkpoint inhibitor blockade	SCIB2 synergy with checkpoint inhibitor blockade	RNS
12/01/15	07:00:10	12 Jan 2015	Positive SCIB1 Phase 1/2 clinical trial update	Positive SCIB1 Phase 1/2 clinical trial update	RNS
15/12/14	17:22:41	15 Dec 2014	Holding(s) in Company	Holding(s) in Company	RNS
10/12/14	07:00:27	10 Dec 2014	Half Yearly Report	Half Yearly Report	RNS
22/10/14	16:07:44	22 Oct 2014	Change of Registered Office	Change of Registered Office	RNS
14/10/14	19:19:56	14 Oct 2014	Result of AGM	Result of AGM	RNS
14/10/14	08:00:15	14 Oct 2014	Appointment of Nominated Adviser and Broker	Appointment of Nominated Adviser and Broker	RNS
14/10/14	08:00:12	14 Oct 2014	AGM research and development update	AGM research and development update	RNS
19/09/14	10:57:21	19 Sept 2014	Notice of AGM	Notice of AGM	RNS
04/09/14	08:00:09	4 Sept 2014	Final Results	Final Results	RNS
12/08/14	08:00:04	12 Aug 2014	Synergy of SCIB1 with checkpoint inhibitors	Synergy of SCIB1 with checkpoint inhibitors	RNS
19/06/14	08:00:20	19 Jun 2014	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
06/06/14	08:00:05	6 Jun 2014	DNA ImmunoBody Patent Granted in United States	DNA ImmunoBody Patent Granted in United States	RNS
02/06/14	08:00:09	2 Jun 2014	Update on Phase 1/2 trial of SCIB1 in melanoma	Update on Phase 1/2 trial of SCIB1 in melanoma	RNS
15/05/14	08:30:02	15 May 2014	Presents latest SCIB1 data at ASCO	Presents latest SCIB1 data at ASCO	RNS
09/05/14	09:30:07	9 May 2014	Directorate Change	Directorate Change	RNS
01/05/14	08:00:15	1 May 2014	Dr Sally Adams to Join as Development Director	Dr Sally Adams to Join as Development Director	RNS
21/03/14	07:00:13	21 Mar 2014	8mg Higher Dose SCIB1 Study On Track	8mg Higher Dose SCIB1 Study On Track	RNS
18/02/14	07:00:20	18 Feb 2014	Publication of Moditope Patent	Publication of Moditope Patent	RNS

Showing 351–400 of 432 announcements